#317, 66 WITHERSPOON ST
PRINCTON, New Jersey - NJ 08542
Phone: 866 409 8111
Fax: 609 228 6151
Contact Office: DrugDev.org
Contact Name: Bill Hare, Chief Legal and Privacy Officer
Phone: 866 409 8111 Fax: 609 228 6151 Email: email@example.com
Corporate Officer Information:
Corporate Officer: Melissa J Easy, Manager
Phone: 866 409 8111 Fax: 609 228 6151 Email: firstname.lastname@example.org
Safe Harbor Information:
Signed up to safe harbor 02/24/2009 12:45:57 PM
Next certification 02/24/2010
EU/EEA Countries From Which Personal Information Is Received: Austria, Czech Republic, France, Iceland, Liechtenstein, Netherlands, Portugal, Spain, Belgium, Denmark, Germany, Ireland, Lithuania, Romania, Sweden, Bulgaria, Estonia, Greece, Italy, Luxembourg, Norway, Slovakia, Switzerland, Cyprus, Finland, Hungary, Latvia, Malta, Poland, Slovenia, United Kingdom
Industry Sector: Information Services - (INF) Drugs & Pharmaceuticals - (DRG) Biotechnology - (BTC)
Personal Information Received From the EU: When someone chooses to register with DrugDev.org they are asked to provide personal information including name, address, phone number, e-mail, job function. Once registered a user may choose to provide other items such as photographs, comments and documents.
DrugDev.org perform surveys and clinical trial feasibilities on behalf of our clients. If the information the user provided us with when they registered matches the profile our clients want responses from, we will email an invitation to a user to participate. As we only hold minimal information about users, they may be required to answer further profiling questions before you are given access to the survey or feasibility. Any information provided by users is given on a voluntary basis. Non-participation will not inhibit their use of our web sites in any way. The information gathered will not be correlated with data about individuals unless they are expressly asked and provide permission. Our clients will be given all anonymous responses.
DrugDev.org may send on behalf of our clients’ prequalification Confidentiality Agreement questionnaire packages ascertaining users interest in participating in a clinical trial. If the information provided when they registered matches the profile our clients require we will send an invitation to participate and reply. As we only hold minimal information about users, they may be required to answer further questions before they are given access to the information and questions. Any information provided is given on a voluntary basis. Non-participation will not inhibit the use of the web sites in any way. If users decide to return a completed questionnaire they will be agreeing for DrugDev.org to provide their name to the named client, they will be reminded of this before submitting any information. Responding to the questionnaire does not automatically grant them participation in the trial; it is merely a way of expressing interest and providing the initial required information.
Users are solely responsible for any photos, profiles, messages and other content they decide to upload or display on the site and can choose to provide none of it without it effecting their use of the website.
Regulated by: Federal Trade Commission
Privacy Programs: Not applicable
Dispute Resolution: EU data protection authorities
Personal Data Covered: All data provided by users on-line
Human Resource Data Covered: No
Do you agree to cooperate and comply with the European Data Protection Authorities? Select Appropriate Response
Certification Status: Current
Safe Harbor Overview | Safe
Harbor Documents | Workbook | Safe Harbor
Information Required for Certification | Certification Form